<DOC>
	<DOCNO>NCT01269658</DOCNO>
	<brief_summary>The purpose study compare safety efficacy azithromycin ophthalmic solution , 1 % versus vehicle four-week treatment period treat sign symptom subject blepharitis evaluate clinical course condition study .</brief_summary>
	<brief_title>A Four Week Study Azithromycin Ophthalmic Solution , 1 % Versus Vehicle Subjects With Blepharitis ( P08636 )</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have current diagnosis blepharitis Have best correct visual acuity ( BCVA ) , use corrective lens necessary , eye least +0.7 If female , nonpregnant nonlactating Have concurrent acute hordeolum ( stye ) chalazion Have inflammation ocular surface Have use artificial tear within 48 hour prior Visit 1 anticipate use study Have ocular surgery past 90 day require study Unable withhold use contact lens study Have know hypersensitivity azithromycin , erythromycin , macrolide antibiotic , ingredient study medication Have diagnose ongoing glaucoma Unable withhold use ocular cosmetic product within 48 hour prior Visit 1 throughout study Have serious medical condition could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>